Menlo Park, CA, United States of America

Michael C Needels

This inventor holds 16 USPTO granted patents and 9 published patent applications. Top assignees: Medikine, Inc., Affymax Technologies, N.v., Affymax, Inc.. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael C Needels. Retrieved from https://idiyas.com/inventor/michael-c-needels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 747(Granted Patents)


Location History:

  • Oakland, CA (US) (1997 - 2002)
  • Menlo Park, CA (US) (2020 - 2024)

Company Filing History:


Years Active: 1997-2024

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Inventor Michael C Needels - Pioneering Innovations in Menlo Park

Introduction: Michael C Needels is a distinguished inventor based in Menlo Park, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Michael C Needels holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Michael C Needels has worked with leading companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Michael C Needels has collaborated with top researchers, engineers, and designers to bring his innovative ideas to life, resulting in successful products and technologies.

Conclusion: Michael C Needels continues to be a driving force in the world of inventions, with his passion for innovation and commitment to excellence shaping the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…